Given the fact that IDH-mutant gliomas peak at the 4th and 5th decades of life and that the IDH wild-type gliomas present with an ever-increasing incidence with age, independent oncogenic processes may be active in IDH-mutant and wild-type gliomas. Here, IDH2 is linked to glioma.